Literature DB >> 29373737

Interleukin 1α (IL-1α) Promotes Pathogenic Immature Myeloid Cells and IL-1β Favors Protective Mature Myeloid Cells During Acute Lung Infection.

Sivakumar Periasamy1, Jonathan A Harton1.   

Abstract

Bacterial pneumonia is a common risk factor for acute lung injury and sepsis-mediated death, but the mechanisms underlying the overt inflammation and accompanying pathology are unclear. Infiltration of immature myeloid cells and necrotizing inflammation mediate severe pathology and death during pulmonary infection with Francisella tularensis. However, eliciting mature myeloid cells provides protection. Yet, the host factors responsible for this pathologic immature myeloid cell response are unknown. Here, we report that while the influx of both mature and immature myeloid cells is strictly MyD88 dependent, the interleukin 1 (IL-1) receptor mediates an important dual function via its ligands IL-1α and IL-1β. Although IL-1β favors the appearance of bacteria-clearing mature myeloid cells, IL-1α contributes to lung infiltration by ineffective and pathologic immature myeloid cells. Finally, IL-1α and IL-1β are not the sole factors involved, but myeloid cell responses during acute pneumonia were largely unaffected by lung levels of interleukin 10, interleukin 17, CXCL1, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29373737      PMCID: PMC6692884          DOI: 10.1093/infdis/jiy049

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

Review 1.  Proinflammatory cytokines.

Authors:  C A Dinarello
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

Review 2.  Innate immunity in the lungs.

Authors:  Thomas R Martin; Charles W Frevert
Journal:  Proc Am Thorac Soc       Date:  2005

3.  MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia.

Authors:  Yoshikazu Naiki; Kathrin S Michelsen; Nicolas W J Schröder; Randa Alsabeh; Anatoly Slepenkin; Wenxuan Zhang; Shuang Chen; Bo Wei; Yonca Bulut; Michelle H Wong; Ellena M Peterson; Moshe Arditi
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

Review 4.  Acute lower respiratory tract infection.

Authors:  Joseph P Mizgerd
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

5.  MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus.

Authors:  Lloyd S Miller; Ryan M O'Connell; Miguel A Gutierrez; Eric M Pietras; Arash Shahangian; Catherine E Gross; Ajaykumar Thirumala; Ambrose L Cheung; Genhong Cheng; Robert L Modlin
Journal:  Immunity       Date:  2006-01       Impact factor: 31.745

6.  A role for IL-1 alpha in inducing pathologic inflammation during bacterial infection.

Authors:  P H Dube; P A Revell; D D Chaplin; R G Lorenz; V L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

7.  Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis.

Authors:  Meenakshi Malik; Chandra Shekhar Bakshi; Bikash Sahay; Aaloki Shah; Steven A Lotz; Timothy J Sellati
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 8.  The role of chemokines in neutrophil biology.

Authors:  Yoshiro Kobayashi
Journal:  Front Biosci       Date:  2008-01-01

9.  Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice.

Authors:  Cecilia G Clement; Scott E Evans; Christopher M Evans; David Hawke; Ryuji Kobayashi; Paul R Reynolds; Seyed J Moghaddam; Brenton L Scott; Ernestina Melicoff; Roberto Adachi; Burton F Dickey; Michael J Tuvim
Journal:  Am J Respir Crit Care Med       Date:  2008-04-03       Impact factor: 21.405

10.  MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus.

Authors:  Camille Bretz; Geoff Gersuk; Sue Knoblaugh; Neelkamal Chaudhary; Julie Randolph-Habecker; Robert C Hackman; Janet Staab; Kieren A Marr
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

View more
  3 in total

1.  Caspase-1 and Caspase-11 Mediate Pyroptosis, Inflammation, and Control of Brucella Joint Infection.

Authors:  Carolyn A Lacey; William J Mitchell; Alexis S Dadelahi; Jerod A Skyberg
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

2.  Emergent high fatality lung disease in systemic juvenile arthritis.

Authors:  Gail H Deutsch; R Paul Guillerman; Johannes Birgmeier; Karthik Jagadeesh; Scott Canna; Grant Schulert; Vivian E Saper; Guangbo Chen; Robin Deterding; Jianpeng Xu; Ann N Leung; Layla Bouzoubaa; Khalid Abulaban; Kevin Baszis; Edward M Behrens; James Birmingham; Alicia Casey; Michal Cidon; Randy Q Cron; Aliva De; Fabrizio De Benedetti; Ian Ferguson; Martha P Fishman; Steven I Goodman; T Brent Graham; Alexei A Grom; Kathleen Haines; Melissa Hazen; Lauren A Henderson; Assunta Ho; Maria Ibarra; Christi J Inman; Rita Jerath; Khulood Khawaja; Daniel J Kingsbury; Marisa Klein-Gitelman; Khanh Lai; Sivia Lapidus; Clara Lin; Jenny Lin; Deborah R Liptzin; Diana Milojevic; Joy Mombourquette; Karen Onel; Seza Ozen; Maria Perez; Kathryn Phillippi; Sampath Prahalad; Suhas Radhakrishna; Adam Reinhardt; Mona Riskalla; Natalie Rosenwasser; Johannes Roth; Rayfel Schneider; Dieneke Schonenberg-Meinema; Susan Shenoi; Judith A Smith; Hafize Emine Sönmez; Matthew L Stoll; Christopher Towe; Sara O Vargas; Richard K Vehe; Lisa R Young; Jacqueline Yang; Tushar Desai; Raymond Balise; Ying Lu; Lu Tian; Gill Bejerano; Mark M Davis; Purvesh Khatri; Elizabeth D Mellins
Journal:  Ann Rheum Dis       Date:  2019-09-27       Impact factor: 19.103

3.  TLR3 Modulates the Response of NK Cells against Schistosoma japonicum.

Authors:  Jiale Qu; Lu Li; Hongyan Xie; Xiaona Zhang; Quan Yang; Huaina Qiu; Yuanfa Feng; Chenxi Jin; Nuo Dong; Jun Huang
Journal:  J Immunol Res       Date:  2018-08-30       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.